<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30210" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Tinea Pedis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nigam</surname>
            <given-names>Pramod K.</given-names>
          </name>
          <aff>PtJNM Med C, Chhattisgarh and AYUSH Uni</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Syed</surname>
            <given-names>Hasnain A.</given-names>
          </name>
          <aff>Sheikh Zayed Hospital, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Saleh</surname>
            <given-names>Dahlia</given-names>
          </name>
          <aff>Sampson Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pramod Nigam declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hasnain Syed declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dahlia Saleh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>10</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30210.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tinea pedis, also known as athlete's foot, results from dermatophytes infecting the skin of the feet.&#x000a0;Patients contract the infection by directly contacting the organism while walking barefoot.&#x000a0;Symptoms typically develop in the interdigital clefts of the toes but can also affect the soles and medial and lateral edges. Generally, physicians treat tinea pedis with topical antifungals and advise maintaining proper foot hygiene for this benign infection.&#x000a0;If not treated appropriately, tinea pedis can lead to significant morbidity, including cellulitis, osteomyelitis, and lymphangitis.&#x000a0;</p>
        <p>A practice gap exists among clinicians in recognizing the risk factors and potential complications associated with tinea pedis. Although it's a common condition, healthcare providers may not be fully aware of the heightened risks in individuals with diabetes and those wearing occlusive shoes. Additionally, there is a need for improved awareness about the progression of untreated tinea pedis, which can lead to severe complications such as cellulitis, pyoderma, and osteomyelitis, especially in immunocompromised patients. Bridging this gap is crucial to ensure timely diagnosis, effective management, and the prevention of complications in patients with this fungal skin infection.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical manifestations and characteristic features of tinea pedis accurately.</p></list-item><list-item><p>Differentiate tinea pedis from other dermatological conditions with similar presentations.</p></list-item><list-item><p>Implement evidence-based treatment strategies, including the appropriate use of topical and oral antifungals, tailored to the severity of the infection.</p></list-item><list-item><p>Coordinate care with other healthcare team members to provide well-rounded support and education for patients at risk of tinea pedis infection, thereby promoting optimal patient outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30210&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30210">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30210.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Tinea pedis, commonly known as athlete's foot, results from fungal infections on the skin of the feet <xref ref-type="bibr" rid="article-30210.r1">[1]</xref><xref ref-type="bibr" rid="article-30210.r2">[2]</xref><xref ref-type="bibr" rid="article-30210.r3">[3]</xref>&#x000a0;caused by dermatophytes, including&#x000a0;<italic toggle="yes">Trichophyton rubrum</italic>,&#x000a0;<italic toggle="yes">T mentagrophytes</italic>,&#x000a0;<italic toggle="yes">T interdigitale</italic>, and&#x000a0;<italic toggle="yes">Epidermophyton floccosum.</italic> This&#x000a0;infection typically occurs through direct contact with the organism while walking barefoot in locker rooms, showers, and swimming complexes.<xref ref-type="bibr" rid="article-30210.r4">[4]</xref>&#x000a0;Individuals with diabetes and those who wear occlusive shoes are at an increased risk of developing tinea pedis.&#x000a0;</p>
        <p>Tinea pedis typically presents with pruritic scales and erosions between the toes. Some patients may experience areas of hyperkeratosis with underlying erythema on the medial and lateral aspects and soles of the feet. Occasionally, patients with this condition may present with&#x000a0;painful bullous lesions concurrently develop tinea corporis, onychomycosis, and tinea manuum.</p>
        <p>Untreated tinea pedis can lead to cellulitis, pyoderma, and osteomyelitis, especially in patients with immunocompromised conditions, diabetes, or peripheral vascular disease. This topic explores the etiology and pathophysiology of tinea pedis, as well as highlights the critical roles of the interprofessional healthcare team in evaluating, managing, and preventing recurrence and complications of the condition.</p>
      </sec>
      <sec id="article-30210.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">T rubrum</italic>&#x000a0;accounts for approximately 70% of tinea pedis cases,<xref ref-type="bibr" rid="article-30210.r5">[5]</xref><xref ref-type="bibr" rid="article-30210.r6">[6]</xref>&#x000a0;whereas&#x000a0;<italic toggle="yes">T interdigitale</italic>&#x000a0;and&#x000a0;<italic toggle="yes">E floccosum&#x000a0;</italic>are responsible for the remainder. Occasionally,&#x000a0;<italic toggle="yes">Tricholosporum violaceum</italic>&#x000a0;can also cause tinea pedis. The United States of America has seen a few cases of <italic toggle="yes">T indotineae&#x000a0;</italic>recently&#x02014;a dermatophyte commonly found in India, Canada, and the Middle East. Notably,&#x000a0;<italic toggle="yes">T indotineaee </italic>exhibits&#x000a0;resistance to traditional antifungal treatments. Dermatophytes typically thrive in keratinized tissues such as hair, nails, and the outer layer of the skin.</p>
        <p>The following factors contribute to the growth of dermatophytes:</p>
        <list list-type="bullet">
          <list-item>
            <p>A hot and humid environment</p>
          </list-item>
          <list-item>
            <p>Prolonged use of tightly fitting footwear</p>
          </list-item>
          <list-item>
            <p>Excessive sweating</p>
          </list-item>
          <list-item>
            <p>Prolonged exposure to water</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30210.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Tinea pedis may affect approximately 10% of the total population. Adult males have a higher prevalence of tinea pedis than females. Wearing occlusive shoes for extended periods predisposes patients to dermatophyte infections. Community facilities involving water are likely to increase the chances of infection, as tinea pedis rates are higher among those who use community baths, showers, and pools.<xref ref-type="bibr" rid="article-30210.r7">[7]</xref> One study reported an average onset age of 15 years.<xref ref-type="bibr" rid="article-30210.r5">[5]</xref><xref ref-type="bibr" rid="article-30210.r8">[8]</xref></p>
      </sec>
      <sec id="article-30210.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The occlusion of toe clefts, maceration, and wet conditions, along with a simultaneous increase in bacterial flora, contribute to tinea pedis infection. Furthermore, skin breakdown, humidity, and temperature also affect this infection. Once the dermatophyte infiltrates the patient's skin, it adheres through adhesins in the fungal cell wall. Proteases, such as serine subtilisin and fungalysin, digest keratin and trigger an immune response. In response, keratinocytes produce cytokines to combat the dermatophyte.&#x000a0;In addition, molecules called "mannans" in the dermatophyte cell wall suppress the body's immune response, making the person more susceptible to infection. Exposure to ultraviolet light, humidity deficiency, and temperature contribute to the body's defense against a dermatophyte infection.</p>
      </sec>
      <sec id="article-30210.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologically, tinea pedis presents with acanthosis, hyperkeratosis, and a sparse, superficial, perivascular infiltrate in the dermis. The vesiculobullous form exhibits spongiosis and parakeratosis. Fungal filaments can be demonstrated through Periodic acid-Schiff staining or methenamine silver stain.</p>
      </sec>
      <sec id="article-30210.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with tinea pedis typically present with long-standing, itchy, intertriginous dermatitis of the toes characterized by peeling, maceration, and fissuring (see <bold>Image.</bold> Tinea Pedis). The undersurface of the toes primarily affects lateral toe clefts, exhibiting erythema and fine, silvery-white scales.&#x000a0;Occasionally, a vesicular eruption resembling pompholyx can appear on the sole, but the most common presentation is the chronic intertriginous type.&#x000a0;</p>
        <p>Chronic hyperkeratotic or moccasin-type tinea pedis typically presents with patchy or diffuse scaling on the bottom, medial, and lateral sides of the feet. The vesiculobullous form, often caused by <italic toggle="yes">T mentagrophytes</italic>, manifests as tense vesicles or bullae on the soles. The burning and itching resulting from bullae can cause significant discomfort. An associated bacterial infection can lead to an acute ulcerative form of tinea pedis.</p>
      </sec>
      <sec id="article-30210.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Although the physical examination may strongly indicate a dermatophyte infection, tinea can overlap with other skin conditions. Confirmation through microscopy and culture may be necessary. A thorough skin examination is warranted as&#x000a0;patients can experience dermatophyte infections in multiple body areas.&#x000a0;</p>
        <p>Microscopic examination of scrapings from the affected site can confirm the diagnosis by demonstrating segmented hyphae.&#x000a0;A glass microscope slide should be used to scrape the foot's instep, heel, and sides to collect dry scales from the foot.&#x000a0;Bullae should be unroofed, and either the entire roof or scrapings made from the underside of the roof should be mounted.</p>
        <p>To perform the procedure, one should place a few drops of a 10% to 20% potassium hydroxide (KOH) solution on the glass slide, followed by a coverslip, and then observe the sample under the microscope. Adding 20% to 40% dimethyl sulfoxide (DMSO) accelerates the clearing of keratin without requiring heating. A staining method that involves mixing 100 mg of chlorazol black E dye with 10 mL of DMSO and adding it to a 5% aqueous solution of KOH can be beneficial. Toluidine blue can also be applied to thin specimens at a concentration of 0.1%. Although mycelia may be visible at low power magnification, using the 10&#x000d7; objective on a microscope is advisable to observe both hyphae and spores better.<xref ref-type="bibr" rid="article-30210.r2">[2]</xref><xref ref-type="bibr" rid="article-30210.r9">[9]</xref><xref ref-type="bibr" rid="article-30210.r10">[10]</xref></p>
      </sec>
      <sec id="article-30210.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Improving hygiene in swimming pools and bathing areas and frequently washing and cleaning changing room floors and walkways may help control the spread of tinea pedis. Most patients can usually manage their condition effectively with topical treatment. Magenta paint or Castellani paint may be beneficial in certain cases of inflammatory tinea pedis, especially when a coexisting bacterial infection is present. Topical imidazoles such as clotrimazole, econazole, ketoconazole, miconazole, isoconazole, tioconazole, and sulconazole offer effective remedies with a very low incidence of adverse effects.</p>
        <p>Topical application of terbinafine and amorolfine yields faster results in treating tinea pedis than clotrimazole treatment. Moreover, adding a topical keratolytic, such as salicylic acid, can be beneficial in patients with hyperkeratosis.&#x000a0;Using prophylactic tolnaftate powder after swimming and showering in community settings reduces the levels of toe cleft tinea pedis caused by <italic toggle="yes">T&#x000a0;interdigitale</italic>. Generally, topical treatment lasts for 4 weeks, although some patients may experience symptom resolution sooner. Terbinafine 1% can provide effective results for interdigital tinea pedis after 1 week. Repeated KOH scrapings and cultures should yield negative results.<xref ref-type="bibr" rid="article-30210.r11">[11]</xref><xref ref-type="bibr" rid="article-30210.r12">[12]</xref><xref ref-type="bibr" rid="article-30210.r13">[13]</xref></p>
        <p>Patients who do not respond to topical treatment require systemic therapy.<xref ref-type="bibr" rid="article-30210.r12">[12]</xref> Acceptable systemic treatment options include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Terbinafine at a daily dosage of 250 mg for 2 weeks.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Itraconazole at a twice-daily dosage of 200 mg for 1 week.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Fluconazole at 150 mg per week for 2 to 6 weeks.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Griseofulvin, for adults, at a daily dosage of 1000 mg of griseofulvin microsize for 4 to 8 weeks or 750 mg of griseofulvin ultramicro size for 4 to 8 weeks. However, the latter option&#x000a0;may be less effective than the other options.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Griseofulvin, for children, at a recommended daily dosage of 10 to 20 mg/kg of griseofulvin microsize, 5 to 15 mg/kg of griseofulvin ultramicrosize, or itraconazole at 3 to 5 mg/kg.<xref ref-type="bibr" rid="article-30210.r14">[14]</xref><xref ref-type="bibr" rid="article-30210.r12">[12]</xref><xref ref-type="bibr" rid="article-30210.r15">[15]</xref></p>
          </list-item>
        </list>
        <p>Although rare, gastrointestinal adverse effects may occur from taking fluconazole. Itraconazole can lead to gastrointestinal upsets, diarrhea, and peripheral edema, particularly when combined with calcium channel blockers. Fluconazole and itraconazole have a significantly lower rate of hepatotoxicity compared to ketoconazole. Terbinafine can also result in gastrointestinal disorders and, in rare cases, hepatitis.<xref ref-type="bibr" rid="article-30210.r16">[16]</xref></p>
      </sec>
      <sec id="article-30210.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The hyperkeratotic lesions of tinea pedis can resemble various conditions, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Psoriasis</p>
          </list-item>
          <list-item>
            <p>Hereditary or acquired keratodermas</p>
          </list-item>
          <list-item>
            <p>Atopic or contact dermatitis</p>
          </list-item>
          <list-item>
            <p>Palmopustular eczema</p>
          </list-item>
          <list-item>
            <p>Pitted keratolysis</p>
          </list-item>
          <list-item>
            <p>Juvenile plantar dermatosis</p>
          </list-item>
          <list-item>
            <p>Keratolysis exfoliativa</p>
          </list-item>
        </list>
        <p>Interdigital lesions may appear similar to the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Psoriasis</p>
          </list-item>
          <list-item>
            <p>Erythrasma</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Candida</italic>&#x000a0;infections</p>
          </list-item>
        </list>
        <p>Vesiculobullous lesions may resemble to the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pustular psoriasis</p>
          </list-item>
          <list-item>
            <p>Dyshidrosis</p>
          </list-item>
          <list-item>
            <p>Acute contact dermatitis</p>
          </list-item>
          <list-item>
            <p>Scabies&#x000a0;</p>
          </list-item>
        </list>
        <p>Reiter syndrome also exhibits lesions that bear some resemblance to those seen in tinea pedis.&#x000a0;</p>
      </sec>
      <sec id="article-30210.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>As long as individuals take preventive measures, the outlook for tinea pedis is favorable. The risk of tinea infections is elevated with excessive sweating, known as hyperhidrosis. To prevent the disease, patients should thoroughly dry their toes after bathing. Maintaining dryness is crucial to prevent reinfection. Individuals susceptible to tinea pedis should wear moisture-wicking socks, apply high-quality antifungal powder inside their shoes, and use drying foot powders after bathing, focusing on the spaces between the toes. Tolnaftate or clotrimazole powders serve as excellent options to maintain dry feet. Regularly applying a topical antifungal cream may be required in certain instances, particularly when wearing hot, enclosed footwear.<xref ref-type="bibr" rid="article-30210.r17">[17]</xref></p>
      </sec>
      <sec id="article-30210.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The majority of patients will not experience significant issues related to tinea pedis. However, complications can arise due to inadequate treatment and persistent skin breakdown.</p>
        <p>
<bold>Secondary Bacterial Infection</bold>
</p>
        <p>Prolonged or severe cases of tinea pedis may result in a secondary bacterial infection. The compromised skin barrier enables bacteria to enter, potentially leading to conditions such as abscess formation.</p>
        <p>
<bold>Impetigo</bold>
</p>
        <p>Tinea pedis can make the affected areas more susceptible to impetigo&#x02014;a highly contagious infection that manifests as honey-colored, crusted lesions capable of spreading to other body parts or individuals through direct contact.</p>
        <p>
<bold>Fungal Nail Infection&#x000a0;</bold>
</p>
        <p>Untreated or inadequately managed tinea pedis can progress to toenail involvement or onychomycosis. Fungal organisms can infiltrate and cause onychomycosis, which is characterized by thickened, discolored, and brittle nails.</p>
        <p>
<bold>Cellulitis</bold>
</p>
        <p>In severe cases, tinea pedis can advance to cellulitis of the foot and leg. Cellulitis manifests as redness, warmth, swelling, and pain in the affected area, often accompanied by systemic symptoms.<xref ref-type="bibr" rid="article-30210.r18">[18]</xref><xref ref-type="bibr" rid="article-30210.r19">[19]</xref></p>
        <p>
<bold>Lymphangitis</bold>
</p>
        <p>Chronic or severe tinea pedis can result in lymphangitis, characterized by the appearance of red streaks extending from the affected area and swelling and tenderness of the lymphatic vessels.</p>
        <p>
<bold>Allergic Contact Dermatitis</bold>
</p>
        <p>Some individuals may experience a local allergic reaction to antifungal medications or other topical treatments for tinea pedis. This can lead to allergic contact dermatitis, characterized by redness, itching, and a rash at the application site.</p>
        <p>
<bold>Chronic or Recurrent Infection</bold>
</p>
        <p>Occasionally, tinea pedis may develop into a chronic or recurrent condition, necessitating long-term management and preventive measures. The persistent nature of the infection can substantially impact the individual's quality of life and foot health.</p>
        <p>Although tinea pedis can be associated with these complications, not all patients will experience them. Prompt and appropriate treatment and adherence to preventive measures can help minimize the risk of complications and contribute to the successful management of tinea pedis.&#x000a0;</p>
      </sec>
      <sec id="article-30210.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Tinea pedis is a fungal infection that affects the skin of the feet.&#x000a0;The individuals at highest risk of developing tinea pedis are those with persistently wet feet, diabetes, immunocompromised conditions, and occlusive shoe wear. The most common places to contract tinea pedis are community showers, swimming pools, and bathing facilities or locker rooms.</p>
        <p>The most prevalent symptoms of tinea pedis are itching, scaling, and developing skin cracks between the toes. In some cases, patients may develop thickening of the skin on the edges and underside of the foot, often accompanied by underlying redness. Most patients apply a topical cream for a duration of 4 weeks, with some experiencing a quicker response. Individuals who do not respond to topical treatment can consider oral therapy. To prevent a recurrence, patients should adhere to several key recommendations.</p>
        <p>The following recommendations can aid in resolving a current infection and preventing future ones:</p>
        <list list-type="bullet">
          <list-item>
            <p>Washing feet daily with mild soap and warm water.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Drying the feet thoroughly after washing them, especially between the toes, after activities that involve water exposure.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Using a separate towel for the feet and avoid sharing it with others.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Discarding old shoes.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Wearing breathable shoes made of natural materials such as leather or canvas.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Avoiding tight-fitting shoes that may create a warm and moist environment promoting fungal growth.<xref ref-type="bibr" rid="article-30210.r20">[20]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Choosing moisture-wicking socks to keep the feet dry.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Wearing flip-flops or sandals in public places such as pools, gyms, and communal showers.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Avoiding sharing shoes, socks, towels, or any other personal items with others.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Inspecting feet for signs of infection, such as redness, itching, or scaling, regularly.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Addressing any cuts, blisters, or breaks in the skin promptly to prevent the entry of fungal organisms.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Wearing breathable shoes and moisture-wicking socks to minimize the risk of reinfection.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Keeping the feet clean, dry, and well-maintained.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Informing family members and close contacts about the tinea pedis infection and educating&#x000a0;them on preventive measures to avoid its spread.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Encouraging family members to follow similar hygiene practices to minimize the risk of spreading the infection.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-30210.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Regularly hosing the floors of shower rooms and the sides of swimming pools decreases the presence of dermatophytes on these surfaces. The use of topical antifungal powder in shoes, such as tolnaftate, can also help reduce the risk of tinea pedis infection. Patients with diabetes with tinea pedis are at a higher risk of developing onychomycosis. Furthermore, the presence of interdigital tinea pedis is a risk factor for cellulitis in patients with lymphoedema.</p>
      </sec>
      <sec id="article-30210.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Tinea pedis is a widespread infection frequently encountered by healthcare professionals. Each member of the interprofessional healthcare team can contribute to preventing future infections and reducing morbidity associated with the infection. Pharmacists can guide patients to the appropriate over-the-counter medication, ensuring they do not use a treatment better suited for a <italic toggle="yes">Candida</italic> infection. Clinicians caring for patients with diabetes can regularly inspect patients' feet and consistently educate them on self-foot care and examinations. As&#x000a0;over-the-counter medications do not appear on shared medication lists, open communication among team members is crucial to prevent the morbidity associated with tinea pedis infection.<xref ref-type="bibr" rid="article-30210.r4">[4]</xref><xref ref-type="bibr" rid="article-30210.r21">[21]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-30210.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30210&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30210">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/tinea-pedis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30210">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30210/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30210">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30210.s17">
        <fig id="article-30210.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Tinea Pedis <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tinea__pedis1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-30210.s18">
        <fig id="article-30210.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Rash, Tinea Pedis, Ringworm of the foot, dermatophytic fungal organism, Skin diseases, infectious, dermatomycoses Contributed by The Centers for Disease Control and Prevention</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="15441_lores" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-30210.s19">
        <fig id="article-30210.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Tinea pedis Contributed by Pramod Kumar Nigam</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Intertrigo" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-30210.s20">
        <fig id="article-30210.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Tinea pedis- plantar xerosis in a moccasin pattern Contributed by Mark A. Dreyer, DPM, FACFAS</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG_8250" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-30210.s21">
        <fig id="article-30210.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Tinea pedis seen in a female patient Contributed by Dr. Hasnain Ali Syed</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tinea__pedis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30210.s22">
        <title>References</title>
        <ref id="article-30210.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Childress</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Common Foot Problems: Over-the-Counter Treatments and Home Care.</article-title>
            <source>Am Fam Physician</source>
            <year>2018</year>
            <month>Sep</month>
            <day>01</day>
            <volume>98</volume>
            <issue>5</issue>
            <fpage>298</fpage>
            <page-range>298-303</page-range>
            <pub-id pub-id-type="pmid">30216025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clebak</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Malone</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Skin Infections.</article-title>
            <source>Prim Care</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>433</fpage>
            <page-range>433-454</page-range>
            <pub-id pub-id-type="pmid">30115333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajagopalan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Inamadar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Miskeen</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Srinivas</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Sardana</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Godse</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rengasamy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rudramurthy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dogra</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Expert Consensus on The Management of Dermatophytosis in India (ECTODERM India).</article-title>
            <source>BMC Dermatol</source>
            <year>2018</year>
            <month>Jul</month>
            <day>24</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">30041646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ilkit</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Durdu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Tinea pedis: the etiology and global epidemiology of a common fungal infection.</article-title>
            <source>Crit Rev Microbiol</source>
            <year>2015</year>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>374</fpage>
            <page-range>374-88</page-range>
            <pub-id pub-id-type="pmid">24495093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lipner</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Scher</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Onychomycosis: Clinical overview and diagnosis.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>80</volume>
            <issue>4</issue>
            <fpage>835</fpage>
            <page-range>835-851</page-range>
            <pub-id pub-id-type="pmid">29959961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Skin microbiome changes in patients with interdigital tinea pedis.</article-title>
            <source>Br J Dermatol</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>179</volume>
            <issue>4</issue>
            <fpage>965</fpage>
            <page-range>965-968</page-range>
            <pub-id pub-id-type="pmid">29704463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shemer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Amichai</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barzilai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farhi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>MacLeod</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Increased Risk of Tinea Pedis and Onychomycosis Among Swimming Pool Employees in Netanya Area, Israel.</article-title>
            <source>Mycopathologia</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>181</volume>
            <issue>11-12</issue>
            <fpage>851</fpage>
            <page-range>851-856</page-range>
            <pub-id pub-id-type="pmid">27435974</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mazza</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Refojo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Davel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lima</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dias</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Passos da Silva</surname>
                <given-names>CMF</given-names>
              </name>
              <name>
                <surname>Canteros</surname>
                <given-names>CE</given-names>
              </name>
              <collab>Mycology Network of the Province of Buenos Aires (MNPBA)</collab>
            </person-group>
            <article-title>Epidemiology of dermatophytoses in 31 municipalities of the province of Buenos Aires, Argentina: A 6-year study.</article-title>
            <source>Rev Iberoam Micol</source>
            <year>2018</year>
            <season>Apr-Jun</season>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>97</fpage>
            <page-range>97-102</page-range>
            <pub-id pub-id-type="pmid">29606407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsunemi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takehara</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Miura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nakagami</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sanada</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawashima</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Specimens processed with an extraction solution of the Dermatophyte Test Strip can be used for direct microscopy.</article-title>
            <source>Br J Dermatol</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>177</volume>
            <issue>3</issue>
            <fpage>e50</fpage>
            <page-range>e50-e51</page-range>
            <pub-id pub-id-type="pmid">27943256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vlahovic</surname>
                <given-names>TC</given-names>
              </name>
            </person-group>
            <article-title>Onychomycosis: Evaluation, Treatment Options, Managing Recurrence, and Patient Outcomes.</article-title>
            <source>Clin Podiatr Med Surg</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>305</fpage>
            <page-range>305-18</page-range>
            <pub-id pub-id-type="pmid">27215153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drago</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Micali</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Papini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piraccini</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Veraldi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Management of mycoses in daily practice.</article-title>
            <source>G Ital Dermatol Venereol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>152</volume>
            <issue>6</issue>
            <fpage>642</fpage>
            <page-range>642-650</page-range>
            <pub-id pub-id-type="pmid">29050446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sahoo</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2016</year>
            <season>Mar-Apr</season>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>77</fpage>
            <page-range>77-86</page-range>
            <pub-id pub-id-type="pmid">27057486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taheri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Onychomycosis treatment in the United States.</article-title>
            <source>Cutis</source>
            <year>2015</year>
            <month>May</month>
            <volume>95</volume>
            <issue>5</issue>
            <fpage>E15</fpage>
            <page-range>E15-21</page-range>
            <pub-id pub-id-type="pmid">26057514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Paquet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>FC</given-names>
              </name>
            </person-group>
            <article-title>Therapies for the treatment of onychomycosis.</article-title>
            <source>Clin Dermatol</source>
            <year>2013</year>
            <season>Sep-Oct</season>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>544</fpage>
            <page-range>544-54</page-range>
            <pub-id pub-id-type="pmid">24079583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roana</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mandras</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Scalas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Campagna</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tullio</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Antifungal Activity of <italic>Melaleuca alternifolia</italic> Essential Oil (TTO) and Its Synergy with Itraconazole or Ketoconazole against <italic>Trichophyton rubrum</italic>.</article-title>
            <source>Molecules</source>
            <year>2021</year>
            <month>Jan</month>
            <day>17</day>
            <volume>26</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">33477259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kably</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Launay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Derobertmasure</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lefeuvre</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dannaoui</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Billaud</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Antifungal Drugs TDM: Trends and Update.</article-title>
            <source>Ther Drug Monit</source>
            <year>2022</year>
            <month>Feb</month>
            <day>01</day>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>166</fpage>
            <page-range>166-197</page-range>
            <pub-id pub-id-type="pmid">34923544</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Nigam</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Syed</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Saleh</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <chapter-title>Tinea Pedis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>10</month>
            <day>29</day>
            <pub-id pub-id-type="pmid">29262247</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Balushi</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Alzaabi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Alghafri</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Prescribing Pattern of Antifungal Medications at a Tertiary Care Hospital in Oman.</article-title>
            <source>J Clin Diagn Res</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>12</issue>
            <fpage>FC27</fpage>
            <page-range>FC27-FC30</page-range>
            <pub-id pub-id-type="pmid">28208876</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Del Rosso</surname>
                <given-names>JQ</given-names>
              </name>
            </person-group>
            <article-title>Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes.</article-title>
            <source>J Clin Aesthet Dermatol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>42</fpage>
            <page-range>42-7</page-range>
            <pub-id pub-id-type="pmid">27047631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sasagawa</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Internal environment of footwear is a risk factor for tinea pedis.</article-title>
            <source>J Dermatol</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>46</volume>
            <issue>11</issue>
            <fpage>940</fpage>
            <page-range>940-946</page-range>
            <pub-id pub-id-type="pmid">31436337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30210.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bowman</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Investigate all the options in skin care.</article-title>
            <source>Prof Nurse</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>19</volume>
            <issue>11</issue>
            <fpage>43</fpage>
            <pub-id pub-id-type="pmid">15317339</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
